Recruiting

Exercise Interventions

Sponsor:

University of Nebraska

Code:

NCT07292272

Conditions

Hematological Malignancy

Leukemia

Lymphoid Leukemia

Multiple Myeloma

Myeloid Leukemia

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Behavioral Coaching Intervention

Virtual Exercise Platform

Study Details

Brief summary:

Older survivors of blood cancer are at a high risk of accelerated biological aging, which increases their risk of developing multiple aging-related conditions. Whereas physical exercise can improve overall health, older cancer survivors do not meet the recommended physical activity, highlighting the need to develop behavioral interventions to increase adherence. Several other knowledge gaps exist to implement exercise interventions in older survivors of blood cancer; the dose and duration of exercise necessary to slow biological aging in older blood cancer survivors remain unknown. To bridge these gaps in knowledge, we have designed a Phase 2 randomized control trial to test the effects of behavioral and exercise interventions on various outcomes.

Conditions

Hematological Malignancy

Leukemia

Lymphoid Leukemia

Multiple Myeloma

Myeloid Leukemia

Study ID

NCT07292272

Start date

Apr 9, 2026

Status verified date

Dec, 2025

Completion date

Mar 25, 2033

Anticipated

Primary completion date

Mar 25, 2032

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Age ≥50 years
2. A history of hematological malignancy
3. Participants must be able to and willingly give informed consent

Exclusion Criteria:

1. Patients receiving intensive induction or consolidation chemotherapy. Maintenance chemotherapy, or lower-intensity chemotherapy for an indolent hematological malignancy is allowed.
2. Neurodegenerative disease (e.g. Alzheimer's dementia), stroke, or uncontrolled psychotic disorders (e.g. schizophrenia or bipolar disorder) in the past 3 months if those disorders are considered significant enough to impair participation in the study.
3. Illnesses such as clinical evidence of decompensated heart failure, unstable angina, or orthopedic or neuromuscular disorders that could limit safe participation in aerobic exercise.
4. Cardiopulmonary exercise test results that preclude safe exercise (e.g., life-threatening arrhythmia, balance difficulties, peak VO2 <10 ml/kg/min).
5. Estimated life expectancy of less than 6 months (that precludes assessment of study primary endpoint).
6. Self-reported pregnancy or the possibility of pregnancy.
7. Participants who do not plan to follow up at the participating center.

Study Design

Enrollment

180 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: Intervention Arm: Exercise + Behavioral Coaching

Intervention arm incorporating virtually supervised moderate-intensity aerobic exercise and behavioral intervention/coaching to improve adherence

active comparator: Enhanced Usual Care-Virtual Gym

Participants will receive access to a virtual exercise platform, and educational sessions but will not receive behavioral coaching

Interventions

Behavioral Coaching Intervention

Intervention arm incorporating virtually supervised moderate-intensity aerobic exercise and behavioral intervention/coaching to improve adherence

Virtual Exercise Platform

Access to a virtual exercise platform that provides exercise classes and educational sessions for older survivors of blood cancer

Primary outcome measure

  • Percentage of participants who adhered to the exercise regimen at 6-months post enrollment. [ Time Frame: 6 Months from start of program ]
  • Percentage of participants who adhered to the exercise regimen at 12-months post enrollment. [ Time Frame: 12 Months from start of program. ]

Central Contacts and Locations

Locations

University of Nebraska Medical Center

Recruiting

Omaha, Nebraska, United States, 68008

Contacts

IIT Office IIT Office

402-559-4596IITOffice@unmc.edu

Principal Investigator:

Vijaya Bhatt, MBBS

More Information

Sponsor

University of Nebraska

Last update posted

Jul 1, 2026

Last verified

Dec, 2025

Keywords

  • Hodgkin Lymphoma
  • Leukemia
  • Lymphoid Leukemia
  • Multiple Myeloma
  • Myeloid Leukemia
  • Monocytic Leukemia
  • Non-hodgkin Lymphoma
  • Other Hematologic Condition
  • Epigenetic clock
  • Biological aging
  • Quality of life
  • Blood cancer survivors

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by University of Nebraska on 2026-07-01.